跳至主要内容
临床试验/NCT05415904
NCT05415904已完成不适用

Hantavirus Nephropathy in North-Eastern France : Severity Risk Factors and Prognostic Tools

Central Hospital, Nancy, France1 个研究点 分布在 1 个国家目标入组 101 人开始时间: 2022年5月20日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
101
试验地点
1
主要终点
Creatinin level

研究概览

简要总结

Hantaviruses are emerging pathogens responsible for hemorrhagic fever with renal syndrome. Severity risks factors aren't consensual in litterature, mostly related to scandinavian cohorts. A prognostic score was created to help patient's orientation in healthcare system but wasn't independantly validated (Hentzien, Emerging infectious diseases 2018).

This retrospective cohort of hantavirus infected hospitalized adults patients in the north-eastern quarter of France between 2013 and 2022 will specify the kidney damage during infection and risk factors for a severe form (defined par acute kidney injury KDIGO 3). The previous prognostic score performance will be evaluated in this cohort.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 125 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • hantavirus proven by serology infection
  • age above 18 years
  • Hospitalisation

排除标准

  • age under 18 years
  • fulfill opposition form

结局指标

主要结局

Creatinin level

时间窗: Through study completion, an average of 2 years

Acute Kidney injury KDIGO 3

Hospitalisation in intensive care unit

时间窗: Through study completion, an average of 2 years

Hospitalisation in intensive care unit

Hemorrhagic syndrome

时间窗: Through study completion, an average of 2 years

Major bleeding requiring blood transfusion

Death

时间窗: Through study completion, an average of 2 years

Death

次要结局

  • calcium(Through study completion, an average of 2 years)
  • Score performance to predict severity(Through study completion, an average of 2 years)
  • Proteinuria(Through study completion,an average of 2 years)
  • Urinary dipstick(Through study completion, an average of 2 years)
  • phosphorus(Through study completion, an average of 2 years)
  • sodium(Through study completion, an average of 2 years)
  • Heamoglobin(Through study completion, an average of 2 years)
  • ALAT, ASAT(Through study completion, an average of 2 years)
  • bicarbonate blood level(Through study completion, an average of 2 years)
  • potassium(Through study completion, an average of 2 years)
  • Urine output(Through study completion, an average of 2 years)
  • Hypotension(Through study completion, an average of 2 years)
  • platelets level(Through study completion, an average of 2 years)

研究者

发起方
Central Hospital, Nancy, France
申办方类型
Other
责任方
Principal Investigator
主要研究者

CORBEL Alice

Principal investigator

Central Hospital, Nancy, France

研究点 (1)

Loading locations...

相似试验